Showing results (491-500 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|April 17, 2008
The T790M "gatekeeper" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitorNadia Godin-Heymann, Lindsey Ulkus, Brian W Brannigan, et al.
Molecular Cancer Therapeutics|April 17, 2008
The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agentsDaekyu Sun, Wei-Jun Liu, Kexiao Guo, et al.
Molecular Cancer Therapeutics|April 17, 2008
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cellsMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Molecular Cancer Therapeutics|April 17, 2008
SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasomeXuefei Cao, Carlos Clavijo, Xu Li, et al.
Molecular Cancer Therapeutics|April 17, 2008
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-rasYanan Yang, Marie Wislez, Nobukazu Fujimoto, et al.
Molecular Cancer Therapeutics|April 17, 2008
Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanismMinsub Shim, Thomas E Eling
Molecular Cancer Therapeutics|August 10, 2019
Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic DysregulationPankaj K Singh, Amit A Deorukhkar, Bhanu P Venkatesulu, et al.
Molecular Cancer Therapeutics|March 31, 2019
Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor ModelTania A Rozgaja Stallons, Amal Saidi, Izabela Tworowska, et al.
Molecular Cancer Therapeutics|March 31, 2019
Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal CancerLeslie Duplaquet, Martin Figeac, Frédéric Leprêtre, et al.
Molecular Cancer Therapeutics|March 31, 2019
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Mitra Nair, Yeshavanth Banasavadi-Siddegowda, et al.
Pageof 599